KRG Capital Partners, a Denver-based private equity firm, announced today the hire of three new managing directors. The new hires, Blair Tikker, Ted Nark, and Stewart Fisher, are all former senior operating executives with prior relationships with KRG.
Tikker began working with KRG in 2006 as a consultant, helping the firm with deal-sourcing and organisational development in its portfolio companies. He was hired as a managing director in May 2007. Previously, he was the Chief Executive Office of HMS Healthcare, a former portfolio company of KRG, as well as a partner in a consulting firm that worked with physician groups, and president of Porter/Littleton hospitals in Colorado.
Nark will join KRG later this month. He was formerly the CEO and chairman of the Board of White Cap Construction Supply, another former portfolio company of KRG, and prior to that the CEO and chairman of Corporate Express Australia, a distributor of office products.
Fisher, who will join KRG in July, was the Chief Financial Officer and Executive VP of administration for Accellent, a provider of manufacturing, supply chain, and engineering services to the medical device industry, and a former portfolio company of KRG. Prior to that, he was the CFO and Executive VP of GenTek, a manufacturer of telecommunications equipment. He was also a manager of corporate finance and capital markets in the treasurer’s office of General Motors.
All three hires come from industries in which KRG has traditionally invested. Furthermore, the new managing directors have experience building up companies through strategic acquisitions.
Tikker was CEO of Sloans Lake Managed Care when it was acquired by KRG in 2001; after two strategic add-ons the company was sold to Aetna under its current name in 2005. Nark has been involved with 75 acquisitions and three industry consolidations in the last 15 years. During Fisher’s time at Accellent the company was built up through nine strategic acquisitions completed by KRG.
Not only will the new hires help the firm to invest its current $715 million fund (€535 million), but the addition of Tikker, Nark and Fisher will help to attract limited partners as the fund prepares to raise its next fund, said Dale Meyer, the firm’s investor relations professional.